Remarkably, our data clearly demonstrate that RMRP can overcome miR-206 inhibition of AKT (Figures 4B,C, 5C,D) and, as thus, trigger AKT-dependent growth and migration of breast cancer cells (Figure 6). The gene discussed is AKT1; the disease is breast cancer.